Filter
866
Filtered Results: 866
Text search:
Paludismo
Featured
Recommendations
73
New Publications
245
Language
Document type
No document type
444
Studies & Reports
169
Guidelines
102
Strategic & Response Plan
57
Fact sheets
30
Manuals
26
Training Material
14
Situation Updates
13
Infographics
7
Resource Platforms
2
Brochures
1
Videos
1
Countries / Regions
Senegal
119
Congo, Democratic Republic of
103
Burkina Faso
64
Benin
62
Madagascar
32
Cameroon
29
Haiti
27
Guinea
22
Paraguay
21
Central African Republic
20
Global
19
Africa
15
Mali
12
Latin America and the Carribbean
11
Togo
10
Niger
10
West and Central Africa
10
Chad
9
Rwanda
7
Côte d’Ivoire / Ivory Coast
7
Mozambique
6
Venezuela
6
East and Southern Africa
5
Colombia
3
Malawi
3
Cambodia
3
Middle East and North Africa
3
Bolivia
3
Argentina
3
Kenya
2
El Salvador
2
Sierra Leone
2
Nigeria
2
Morocco
2
South–East Asia Region
2
Ethiopia
2
Mexico
1
Chile
1
Canada
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Peru
1
Mauritania
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Uruguay
1
France
1
Tunisia
1
Spain
1
Algeria
1
South Africa
1
Nicaragua
1
Honduras
1
Angola
1
Libya
1
Botswana
1
Zambia
1
Somalia
1
Ecuador
1
India
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
497
Clinical Guidelines
133
Public Health
44
Women & Child Health
36
Key Resources
25
Pharmacy & Technologies
16
Capacity Building
7
Toolboxes
COVID-19
55
Ebola
48
Rapid Response
25
AMR
21
HIV
19
TB
18
Planetary Health
17
Caregiver
16
NTDs
15
Mental Health
14
Disability
14
Pharmacy
12
Zika
8
Natural Hazards
7
Polio
5
Refugee
4
Cholera
3
NCDs
3
Health Financing Toolbox
2
Conflict
2
Global Health Education
2
How can we eradicate malaria? Explore cutting-edge science and technology, and examine policies needed, to control and eliminate malaria.
(African Development Bank policy research document 1)
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in Africa without health aid. It also presents a theoretic...
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in Africa without health aid. It also presents a theoretic...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
Because malaria cases are seen relatively rarely in North America, misdiagnosis by clinicians and laboratorians has been a commonly documented problem in published reports. However, malaria may be a common illness in areas where it is transmitted and therefore the diagnosis of malaria should routine...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Chemoprevention is the use of medicines, either alone or in combination, to prevent malaria infection and its consequences. This publication provides standardized approaches for monitoring and evaluating the efficacy of medicines used for intermittent preventive treatment of malaria in pregnancy, pe...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
This document provides an overview of malaria trends in all WHO regions as contained in the World malaria report 2022.
Anopheles stephensi, a highly competent vector of Plasmodium falciparum and P. vivax, is considered an efficient vector of urban malaria. Until 2011, the reported distribution of An. stephensi was confined to certain countries of South Asia and parts of the Arabian Peninsula. Since then, the vector ...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Guidance on the prioritization of insecticide-treated nets in situations where resources are limited
In the context of limited resources, national malaria programmes may need to decide on how to prioritize all WHO-recommended interventions . This guidance document has been developed to support national malaria programmes in prioritization decisions, specifically on the deployment scope and product ...
This report describes the activities of the WHO European Centre for Primary Health Care in 2022.The Centre accelerated face-to-face country support after the wake of the COVID-19 pandemic to support countries in engaging in analysis and diagnosis, developing strategies and policies, building capacit...
Tracking global malaria spending provides insight into how far the world is from reaching the malaria funding target of $6·6 billion annually by 2020. Because most countries with a high burden of malaria are low income or lower-middle income, mobilising additional government resources for malaria m...
Anopheles stephensi is a mosquito species that is capable of transmitting both Plasmodium falciparum and P. vivax malaria parasites. Unlike the other main mosquito vectors of malaria, it thrives in urban and man-made environments. Originally native to parts of South Asia and the Arabian Peninsula, A...
This action plan is intended for senior-level decision-makers in ministries of health, malaria
programme managers, entomologists, and epidemiologists working on malaria and other vectorborne diseases programmes. It is also intended for decision-makers and technical and advocacy
staff at other orga...
This publication describes the reasons for the resurgence of malaria in Kyrgyzstan and presents an analysis of evidence-based elimination strategies and policies that were applied to contain the epidemic and outbreaks of the disease, achieve its elimination, and maintain the country malaria-free. Th...
Each year, WHO’s World malaria report provides a comprehensive and up-to-date assessment of trends in malaria control and elimination across the globe. This year’s report includes, for the first time, a dedicated chapter focused on the intersection between climate change and malaria. As describe...
Fact Sheet
